Inventor · disambiguated record
Eike Hoffmann
Also filed as: HOFFMANN EIKE
16 granted patents·12 pending applications·223 citations·filing 1997–2025
92Inventor score
Files withHOFFMANN LA ROCHE16BRINKMANN ULRICH5BOSSENMAIER BIRGIT2ROCHE DIAGNOSTICS GMBH2BRAMLAGE BIRGIT1
Top patents by PatentIndex Score
28 records- 0194US9890204B2Trivalent, bispecific antibodiesBRINKMANN ULRICH·Filed 2012·Granted Feb 13, 2018·27 cites·11 claims
- 0289US6767887B1Exendin analogues, processes for their preparation and medicaments containing themROCHE DIAGNOSTICS GMBH·Filed 1997·Granted Jul 27, 2004·142 cites·54 claims
- 0387US9765153B2Anti-biotin antibodies and methods of useHOFFMANN LA ROCHE·Filed 2014·Granted Sep 19, 2017·7 cites·20 claims
- 0487US8907069B2Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agentBRINKMANN ULRICH·Filed 2010·Granted Dec 9, 2014·7 cites·17 claims
- 0582US9050375B2Bi-specific digoxigenin binding antibodiesBRAMLAGE BIRGIT·Filed 2010·Granted Jun 9, 2015·6 cites·17 claims
- 0678US10517945B2Covalently linked antigen-antibody conjugatesHOFFMANN LA ROCHE·Filed 2014·Granted Dec 31, 2019·3 cites·16 claims
- 0778US9925272B2Anti-theophylline antibodies and methods of useHOFFMANN LA ROCHE·Filed 2014·Granted Mar 27, 2018·3 cites·15 claims
- 0877US10519249B2Covalently linked polypeptide toxin-antibody conjugatesHOFFMANN LA ROCHE·Filed 2016·Granted Dec 31, 2019·2 cites·8 claims
- 0975US10407511B2Covalently linked helicar-anti-helicar antibody conjugates and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Sep 10, 2019·2 cites·9 claims
- 1073US2025361326A1Method for generating multispecific antibodies from monospecific antibodiesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1170US11993642B2Trivalent, bispecific antibodiesHOFFMANN LA ROCHE·Filed 2019·Granted May 28, 2024·0 cites·10 claims
- 1269US2025361325A1Method for generating multispecific antibodies from monospecific antibodiesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1367US9574016B2Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agentHOFFMANN LA ROCHE·Filed 2014·Granted Feb 21, 2017·0 cites·8 claims
- 1466US12023378B2Covalently linked antigen-antibody conjugatesHOFFMANN LA ROCHE·Filed 2019·Granted Jul 2, 2024·0 cites·21 claims
- 1566US6429288B1Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compoundsROCHE DIAGNOSTICS GMBH·Filed 1998·Granted Aug 6, 2002·24 cites·8 claims
- 1664US12297290B2Method for generating multispecific antibodies from monospecific antibodiesHOFFMANN LA ROCHE·Filed 2020·Granted May 13, 2025·0 cites·15 claims
- 1759US2010081796A1Bispecific anti-egfr/anti-igf-1r antibodiesBRINKMANN ULRICH·Filed 2009·Application pending·0 cites
- 1859US2018282399A1Trivalent, bispecific antibodiesHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 1955US2014135482A1Bispecific Anti ErbB3 / Anti cMet AntibodiesROCHE GLYCART AG·Filed 2014·Application pending·0 cites
- 2051US10137170B2Lipidated incretin receptor ligand human immunoglobulin Fc-region fusion polypeptidesUNIV INDIANA RES & TECH CORP·Filed 2014·Granted Nov 27, 2018·0 cites·3 claims
- 2151US2010256340A1Trivalent, bispecific antibodiesBRINKMANN ULRICH·Filed 2010·Application pending·0 cites
- 2250US7956190B2Benzimidazole amido derivatives as kinase inhibitorsHOFFMANN LA ROCHE·Filed 2008·Granted Jun 7, 2011·0 cites·10 claims
- 2350US2022033525A1Generation of antibody-derived polypeptides by polypeptide chain exchangeHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2445US2012149879A1Bispecific anti-egfr/anti-igf-1r antibodiesBRINKMANN ULRICH·Filed 2011·Application pending·0 cites
- 2544US2006116407A1Amide derivativesBOSSENMAIER BIRGIT·Filed 2005·Application pending·0 cites
- 2644US2010256339A1Bispecific Anti ErbB3 / Anti cMet AntibodiesBOSSENMAIER BIRGIT·Filed 2010·Application pending·0 cites
- 2742US2013280279A1Pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptideHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2841US2016333386A1Use of peptidylglycine alpha-amidating monooxigenase (pam) for c-terminal amidationHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eike Hoffmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →